Global Program Leader (Exec Dir Level) | Ph 3/Later-Stage Programs | Top Global Rare Disease Co | Boston or Home Based

Cornerstone Search Group
Published
September 21, 2020
Location
Remote OR Greater Boston Area, United States
Category
Job Code
cmBH2794csg
Contact Email
cmiras@cornerstonesg.com

Description

Global Program Leader (Exec Dir Level) | Ph 3/Later-Stage Programs | Top Global Rare Disease Co | Boston or Remote (Home Based)

SUMMARY:

You will be the Global Program Leader and the “go to” person that Sr. Executive and Therapeutic Area Leadership communicate with for key information about the strategies, plans, status/progress, etc. for the Multiple Later-Stage Development Programs for one of this Top Global Rare Disease’s Co’s assets.

You will be the key person looking at the clinical development, regulatory filing, manufacturing, launch, commercialization and more from a 30,000 foot view to successfully plan, execute, identify and mitigate/eliminate/manage risks and more to ensure swift clinical development, regulatory filings and commercialization of this highly-innovative/complex rare disease asset to treat multiple indications.

This is a very attractive role for an accomplished industry professional with a wide breadth of knowledge about the what, why, when and how things should be planned out to successfully plan, organize, execute and manage the multiple global functions to progress a Program/Asset from early to later-stage Clinical Development through to Launch without being the Subject Matter Expert/SME in all functional areas involved/contributing to the development, filing, approval, commercialization & LCM of the asset. You will enjoy an opportunity to use your strong leadership, communication, facilitation, negotiation, people … skills and capabilities to help navigate and bring important novel Rare Disease therapies to both pediatric and adult patients suffering with immunological, neurological and other chronic and life threatening Rare Diseases.

LOCATION:

This Global Program Leadership position can be based remotely (from home anywhere in the USA) or it can be based in one of the Company’s offices located on the East Coast (HQ is located in the Boston/Cambridge area). They also have a West Coast office too where this position can be based.

ATTRACTIVE FEATURES INCLUDE:

  • Visibility: you will be the “go to” person by Sr. Management for information about your major Global Programs
  • Leadership: you will lead global, highly matrixed, and multi-functional teams to achieve major clinical development, regulatory filing, product launch, commercialization, and LCM objectives
  • Strategy Influence and Impact: you will be a major contributor to the key strategic discussions and decisions made for your asset’s programs   
  • Top Novel Rare Disease Pipeline: join a company with a very deep & diverse pipeline of early & later-stage novel Rare Disease assets to treat important immunological, neurological, and other diseases and disorders with few or no available treatments   
  • Proven Success: join a Rare Diseases Industry Leader with multiple development successes (i.e. FDA approvals)
  • Strategic Collaborations: join a Rare Diseases company with a track record of establishing multiple collaborations with other innovative biotech companies too in a highly competitive marketplace
  • R&D Spend: join a Rare Diseases company that has and continues to invest significantly in its annual R&D spend
  • Commitment to Important Rare Diseases: join a company that has been and continues to commit its financial and human capital to persevere in its efforts to develop multiple novel and innovative therapies with a “sense of urgency”
  • Enjoy the best of what biotech and pharma have to offer (best of both worlds): enjoy the minimal layers of management and swift decision making of a biotech culture, while also enjoying the financial stability and the financial strength of an established global biopharma (i.e. more financial and human capital resources, a deeper pipeline, a very competitive compensation and benefits package and more
  • Receive a very competitive compensation package: join a company that offers one of the most competitive compensation packages in the pharma/biopharma industry

QUALIFICATIONS:

  • PhD or MD
  • 10+ years of pharma/biotech industry experience with a track record of increasing responsibility
  • Proven track record of Program Leadership/Management experience, especially with later-stage assets
  • Strong communication skills, i.e. writing, oral and presentation skills
  • Strong interpersonal skills to effectively facilitate, negotiate, and influence others at all levels
  • Proven track record of effectively interacting, presenting to, and communicating with Sr. Level Management (ad-hoc & formal)

CONFIDENTIALITY:

All inquiries and communications with Cornerstone Search Group are treated as confidential information.

CONTACT:

Cliff Miras | Managing Partner

E: cmiras@cornerstonesg.com

P: 973.656.0220 x711

LinkedIn: linkedin.com/in/cliffmiras

CORNERSTONE SEARCH GROUP

Pharma/Biotech Executive Search Specialists | A Forbes “Top 250 Search Firm” for 2018 & 2017

www.cornerstonesg.com

Recently Completed Search Assignments:

  • CEO | US Country Head, Specialty Pharma
  • CEO | Start-up sterile injectable pharma
  • CMO | NYC biotech, Cellular Therapy
  • CMO | Reports to CEO | Leads 100+ | Early/later-stage Biotech | Boston area
  • CSO | Reports to President | Leads 850+ | Hem/Onc/IO TAs | EU based
  • SVP, Global Medical Affairs, Oncology | Reports to President | Leads 50+ | NYC area
  • SVP, Translational Medicine & Early Development, Oncology | Boston Biotech
  • VP, Program Leadership | A Top Global Immuno-Oncology R&D Company | Boston area
  • VP, Oncology Drug Development | Reports to CMO | Leads 20+ | Early/later-stage Biotech | Boston
  • VP & Head of Research & Development, Oncology | Reports to CMO | Early-stage Biotech | NYC
  • VP, US Medical Affairs, Oncology | Reports to Head of GMA, Oncology | Leads 45+ team | NYC area
  • VP, Head of Real-World Evidence | Top 5 Pharma
  • 3 RWE TA Heads for newly-created RWE department at mid-size pharma | Boston Biotech
  • VP, Head of Clinical Operations
  • ED, Early Development, IO | Reports to Head, IO Early R&D | Top 10 Onc/IO Co | Philadelphia area
  • ED, Clinical R&D, Onc | Reports to Head. Clinical R&D Onc | Preclinical Onc/IO Biotech | NYC area
  • ED, Head of Program Management | Boston Biotech
  • SD, Clinical Research, Oncology | Boston Area Biopharma Oncology Leader
  • SD, Clinical Development, Immuno-Oncology | Cambridge Area Global Oncology Leader

Keywords: GPL, Program, Asset, Oncology, Hematology, Immuno-Oncology, Cancer, Tumor, Project, Timeline, Regulatory, Clinical Research, Clinical Development, Global, Leadership, Executive, Business, Therapeutic Area, Commercial, Pricing, Reimbursement, Health Economic, HEOR, Outcomes, Real World Evidence, Medical Affairs, Operations, Translational, Launch, LCM, lifecycle, manager, leader, real world evidence, RWE, real-world, health economics, value, HE&OR, market access, reimbursement, Ph.D., doctorate, strategy, strategic, CEO, Chief, Leader, Head, GPH, GPT

Apply
Drop files here browse files ...
PDF and .doc resume uploads are preferred. docx files are not supported.
Captcha